Medarex Investor Sues Over $2B Bristol-Myers Sale
A Medarex Inc. investor has sued Medarex, its board of directors and Bristol-Myers Squibb Co., alleging that Bristol-Myers' plans to acquire the biologics company in a $2.1 billion deal are both...To view the full article, register now.
Already a subscriber? Click here to view full article